Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.
Scope of the Report:
This report focuses on the Large Volume Wearable Injectors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In the coming years there is an increasing demand for Large Volume Wearable Injectors in the regions of US and Europe that is expected to drive the market for more advanced Large Volume Wearable Injectors. Increasing of the cancer, auto-immune, blood disorders and stable rise in aging population will drive growth in United States and Europe markets.
Globally, the Large Volume Wearable Injectors industry market is concentrated as the manufacturing technology of Large Volume Wearable Injectors is relatively matures than some high-tech equipment. And some enterprises, like West, Unilife, CeQur, etc. are well-known for the wonderful performance of their Large Volume Wearable Injectors and related services. At the same time, United States, occupied 64.61% production market share in 2015, is remarkable in the global Large Volume Wearable Injectors industry because of their market share and technology status of Large Volume Wearable Injectors.
The consumption volume of Large Volume Wearable Injectors is related to downstream industries and global economy. As there will always be some uncertain in the global economy in the following years, the growth rate of Large Volume Wearable Injectors industry may not keep that fast. But it is surely forecasted that the market of Large Volume Wearable Injectors is still promising.
The worldwide market for Large Volume Wearable Injectors is expected to grow at a CAGR of roughly 140.4% over the next five years, will reach 6680 million US$ in 2023, from 35 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
J & J
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
Blood Disorders Treatment
There are 15 Chapters to deeply display the global Large Volume Wearable Injectors market.
Chapter 1, to describe Large Volume Wearable Injectors Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Large Volume Wearable Injectors, with sales, revenue, and price of Large Volume Wearable Injectors, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Large Volume Wearable Injectors, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Large Volume Wearable Injectors market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Large Volume Wearable Injectors sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source